Decreases in serum levels of S100 may predict response to therapy in melanoma patients treated with a polyvalent melanoma vaccine

被引：0
|
作者：
Bar, A [1 ]
Amin, P [1 ]
Reynolds, S [1 ]
Shapiro, R [1 ]
Roses, D [1 ]
Harris, M [1 ]
Bystryn, J [1 ]
机构：
[1] NYU, Sch Med, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2001年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
901
引用
收藏
页码：540 / 540
页数：1
相关论文
共 50 条
  • [21] Rising levels of serum S100 protein precede other evidence of disease progression in patients with malignant melanoma
    Jury, CS
    McAllister, EJ
    MacKie, RM
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 556 - 556
  • [22] Rising levels of serum S100 protein precede other evidence of disease progression in patients with malignant melanoma
    Jury, CS
    McAllister, EJ
    MacKie, RM
    BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (02) : 269 - 274
  • [23] Relevance of MIA and S100 serum tumor markers to monitor BRAF inhibitor therapy in metastatic melanoma patients
    Sanmamed, Miguel F.
    Fernandez-Landazuri, Sara
    Rodriguez, Carmen
    Lozano, Maria D.
    Echeveste, Jose I.
    Perez Gracia, Jose Luis
    Alegre, Estibaliz
    Carranza, Omar
    Zubiri, Leyre
    Martin-Algarra, Salvador
    Gonzalez, Alvaro
    CLINICA CHIMICA ACTA, 2014, 429 : 168 - 174
  • [24] Relative Change in S100 as a Biomarker of Survival in Patients With Metastatic Melanoma Treated With Pembrolizumab
    Simetic, Luka
    Blazicevic, Kresimir
    Medugorac, Kata
    Golcic, Marin
    Herceg, Davorin
    ANTICANCER RESEARCH, 2020, 40 (04) : 2157 - 2163
  • [25] Serum levels of S-100 protein in advanced melanoma patients
    Leporowska, E
    Karczewska-Dzionk, A
    Karczmarek, A
    Mackiewicz, A
    CLINICA CHIMICA ACTA, 2005, 355 : S429 - S429
  • [26] Serum angiogenin levels predict treatment response in patients with stage IV melanoma
    Pia Vihinen
    Minna Kallioinen
    Meri-Sisko Vuoristo
    Johanna Ivaska
    Kari J. Syrjänen
    Marjo Hahka-Kemppinen
    Pirkko-Liisa Kellokumpu-Lehtinen
    Seppo O. Pyrhönen
    Clinical & Experimental Metastasis, 2007, 24 : 567 - 574
  • [27] Serum angiogenin levels predict treatment response in patients with stage IV melanoma
    Vihinen, Pia
    Kallioinen, Minna
    Vuoristo, Meri-Sisko
    Ivaska, Johanna
    Syrjanen, Kari J.
    Hahka-Kemppinen, Marjo
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Pyrhonen, Seppo O.
    CLINICAL & EXPERIMENTAL METASTASIS, 2007, 24 (07) : 567 - 574
  • [28] Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors
    Maximilian Gassenmaier
    Max M. Lenders
    Andrea Forschner
    Ulrike Leiter
    Benjamin Weide
    Claus Garbe
    Thomas K. Eigentler
    Nikolaus B. Wagner
    Targeted Oncology, 2021, 16 : 197 - 205
  • [29] Long-term survival of stage IV melanoma patients treated with a polyvalent, shed antigen, melanoma vaccine
    Laky, D
    Shapiro, RL
    Harris, MN
    Roses, DF
    Jacquotte, AZ
    Reynolds, SR
    Bystryn, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 240 - 240
  • [30] Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors
    Gassenmaier, Maximilian
    Lenders, Max M.
    Forschner, Andrea
    Leiter, Ulrike
    Weide, Benjamin
    Garbe, Claus
    Eigentler, Thomas K.
    Wagner, Nikolaus B.
    TARGETED ONCOLOGY, 2021, 16 (02) : 197 - 205
12345